Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 7
1991 5
1992 4
1993 2
1994 2
1995 6
1996 11
1997 3
1998 3
2000 4
2001 1
2002 9
2003 5
2004 4
2005 1
2006 3
2007 5
2008 9
2009 4
2010 6
2011 7
2012 4
2013 4
2014 6
2015 4
2016 2
2017 6
2018 2
2019 2
2020 2
2021 7
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Clinical manifestations and immune response to tuberculosis.
Carabalí-Isajar ML, Rodríguez-Bejarano OH, Amado T, Patarroyo MA, Izquierdo MA, Lutz JR, Ocampo M. Carabalí-Isajar ML, et al. Among authors: izquierdo ma. World J Microbiol Biotechnol. 2023 May 24;39(8):206. doi: 10.1007/s11274-023-03636-x. World J Microbiol Biotechnol. 2023. PMID: 37221438 Free PMC article. Review.
Transporter molecules in multidrug resistance.
Scheper RJ, Scheffer GL, Flens MJ, van der Valk P, Broxterman HJ, Izquierdo MA. Scheper RJ, et al. Among authors: izquierdo ma. Cytotechnology. 1996;19(3):187-90. doi: 10.1007/BF00744211. Cytotechnology. 1996. PMID: 8862005 Review. No abstract available.
Major vault protein LRP-related multidrug resistance.
Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, van der Valk P, Scheper RJ. Izquierdo MA, et al. Eur J Cancer. 1996 Jun;32A(6):979-84. doi: 10.1016/0959-8049(96)00053-6. Eur J Cancer. 1996. PMID: 8763338 Review. No abstract available.
Imaging tumor microscopic viscosity in vivo using molecular rotors.
Shimolina LE, Izquierdo MA, López-Duarte I, Bull JA, Shirmanova MV, Klapshina LG, Zagaynova EV, Kuimova MK. Shimolina LE, et al. Among authors: izquierdo ma. Sci Rep. 2017 Jan 30;7:41097. doi: 10.1038/srep41097. Sci Rep. 2017. PMID: 28134273 Free PMC article.
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Moreno-Aspitia A, Holmes EM, Jackisch C, de Azambuja E, Boyle F, Hillman DW, Korde L, Fumagalli D, Izquierdo MA, McCullough AE, Wolff AC, Pritchard KI, Untch M, Guillaume S, Ewer MS, Shao Z, Sim SH, Aziz Z, Demetriou G, Mehta AO, Andersson M, Toi M, Lang I, Xu B, Smith IE, Barrios CH, Baselga J, Gelber RD, Piccart-Gebhart M; ALTTO Steering Committee and Investigators. Moreno-Aspitia A, et al. Among authors: izquierdo ma. Eur J Cancer. 2021 May;148:287-296. doi: 10.1016/j.ejca.2021.01.053. Epub 2021 Mar 23. Eur J Cancer. 2021. PMID: 33765513 Free PMC article. Clinical Trial.
132 results